Financials

Company Profile

IMV Inc. is a Canada-based company. The Company has sold all of its assets. It is not engaged in any business operations.

Employees

Sector

24/04/24	OPEC excited about Namibia partnership, offers support	RE
16/03/23	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
11/11/22	IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
11/08/22	IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
29/06/22	IMV Inc. - Shareholder/Analyst Call

04/09/23	IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	AQ
13/06/19	IMV Inc. : to Present at Two Upcoming Investor Conferences	BU
12/06/19	Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	BU

Manager	Title	Age	Since
Stéphane Fiset CTO	Chief Tech/Sci/R&D Officer	-	-
Tracy Sherren SEC	Corporate Secretary	60	-
Marie-Eve Charrois LAW	General Counsel	-	-

Director	Title	Age	Since
Markus Warmuth BRD	Director/Board Member	55	05/11/2018
Michael Bailey CHM	Chairman	60	30/04/2022
Michael Kalos BRD	Director/Board Member	64	10/05/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMV INC	+11.37%	+4.00%	-	-	14
BOXABL INC.	+5.33%	-59.88%	-60.20%	-	11.82B
FREENOME, INC.	-6.94%	-4.77%	+7.36%	-	1.28B
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-.--%	-3.48%	915M
PRIME BEING CORP.	-30.77%	+63.64%	+136.84%	+359,900.00%	797M
CHURCHILL CAPITAL CORP XI	-3.57%	-10.99%	-	-	764M
CENTIEL AG	-2.67%	+2.50%	+292.81%	-66.19%	672M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.05%	+0.30%	-	-	644M
CHURCHILL CAPITAL CORP XII	0.00%	-1.38%	-	-	605M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	-.--%	-.--%	-.--%	600M
Average	-2.92%	-5.04%	+62.80%	+89,957.58%	2.01B
Weighted average by Cap.	+1.31%	-33.43%	-24.63%	+96,101.64%